BioPharmaSpec
is a Private company. Andrew Reason is the CEO of BioPharmaSpec. BioPharmaSpec's main competitors are OMass, Enteris BioPharma and Cognition. BioPharmaSpec has 2 followers on Owler.BioPharmaSpec
is a Private company. Andrew Reason is the CEO of BioPharmaSpec. BioPharmaSpec's main competitors are OMass, Enteris BioPharma and Cognition. BioPharmaSpec has 2 followers on Owler.
News
Dec 12, 2024
Biopharmaspec Blog
Biopharmaspec Blog Driving Innovation in Biopharmaceutical Characterization: BioPharmaSpec’s New Facilities and Advanced Instrumentation
Nov 21, 2024
Manufacturing Chemist
BioPharmaSpec: BioPharmaSpec expands its biopharma discovery and preclinical capabilities with three new facilities
Nov 14, 2024
Biopharmaspec Blog
Biopharmaspec Blog Revolutionizing Secondary Structure and Stability Measurements at BioPharmaSpec
Oct 08, 2024
Biopharmaspec Blog
Biopharmaspec Blog The use of Evaporative Light Scattering Detection (ELSD) in Residual and Impurity Testing
Sep 16, 2024
Biopharmaspec Blog
Biopharmaspec Blog L- and D-Amino Acids: Are They Different and Does it Matter?
Aug 12, 2024
Biopharmaspec Blog
Biopharmaspec Blog EMA “Report Card” 2023
Jul 08, 2024
Biopharmaspec Blog
Biopharmaspec Blog Bioinformatics at BioPharmaSpec: Adding value to your structural characterization projects
Jun 12, 2024
Biopharmaspec Blog
Biopharmaspec Blog Robust Considerations
Jun 03, 2024
The Korea Bizwire
BioPharmaSpec: BioPharmaSpec Announces Major Investments in Mass Spectrometry and Related Instrumentation
May 23, 2024
Biopharmaspec Blog
Biopharmaspec Blog Biosimilar milestones in the US
BioPharmaSpec Competitors
1
2
3
4
5
6
7
8
9
10